| Code | 2749E | ||||||||||
| MA number | 09/0026/23-S | ||||||||||
| Product Form: | plv ifo 1x40 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zentiva, k.s., Czechia | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 26.01.2023 |
| Validity: | 26.01.2028 |
| PIL: |
PIL_Omeprazole Zentiva_plv ifo_05_2023.pdf
|
| SPC: |
SPC_Omeprazole Zentiva_plv ifo_05_2023.pdf
|
| Safety feature | Yes |
| Data update: | 14.02.2023 |
